NEWS
SSRP Institute
Jun 04, 2025

A Statement Regarding Peptide Sourcing

ADVISORY BULLETIN

The SSRP is a medical education institute. We do not sell peptides. Our platform serves as a global scientific forum which promotes peptide science alongside cellular medicine education and clinical applications. It enables open dialogue and innovation through its support of the highest ethical and legal standards.

Our mission is to “improve patient outcomes, together”. This includes informing you how to protect both your patients and your license. Please take the time to discern the differences in peptide sourcing. This information is crucial for the safety of your patients, and the legal risks to you and your practice.

RUO Peptides

Some companies solicit research-use-only (RUO) peptides that exist outside human drug approval and/or prescription requirements. These products are for laboratory, educational, and investigational purposes only, not clinical, therapeutic, or diagnostic applications. They are labeled “not for human use” or “for research use only” as a legal disclaimer in an attempt to remove liability from the manufacturer in the context of human administration. Clinically prescribing or administering RUO peptides — even if they are third-party tested — violates federal and state board of pharmacy laws. The FDA sees this as misbranding and distribution of unapproved new drugs, and it’s legally indefensible in a court of law. Providers can get sued, have their license suspended, and face jail time for offering RUO meds directly from their clinics.

What If They Claim They’re Not RUO?

Even when a vendor claims their peptides are “pharma-grade” or “direct from manufacturer,” unless they are a licensed pharmacy, they are not legally authorized to sell medications for human use — and neither 3rd-party testing nor disclaimers remove this liability.

Compounded Peptides

If you have specific questions about how to source peptides appropriately, please reach out to your preferred compounding pharmacy. If you do not have one, we have several listed publicly on our website. Compounding pharmacies exist inside of a highly regulated, prescription drug supply chain. If you cannot find a particular peptide within their formulary, ask about substitutes they offer. If they do not ship to your state, ask your local compounding pharmacist how you can support them in their efforts to continue providing legitimate custom peptides for patients.

In Summary

Online injectable peptides that are not received from a legitimate compounding pharmacy are illegal. Period. Clinics can get raided, and providers can get shut down, if they are found to be prescribing them and storing them with intent to use clinically.

Compounding pharmacies compound drugs for human use for individually identified patients pursuant to a medical provider’s prescription. They ship directly to the patient, and patients’ rights to peptide therapy are protected under federal patient personal use laws.

Please consult with your legal counsel to ensure that, if you’re going to provide appropriate clinical guidance on peptide therapy, you’re doing so in a way that protects your patient’s health and your ability to continue to better ensure their safety.

RELATED RESOURCES

Continue exploring related topics.

VIEW ALL
VIDEO
Cellular Medicine Mondays
Nov 2, 2026
Ep. 112 - Peptide Therapy Gets a Smarter Upgrade
Preview only
Dissecting Protocols – Episode 112

Peptide Therapy Gets a Smarter Upgrade

Dr. Seeds addresses the often-overlooked challenges of peptide purity, patient adherence, and administration. He also shares the journey behind the Redox Smart Pen, highlighting years of collaboration with scientists, physicians, and formulators to help raise the standard for peptide therapy and advance the future of cellular medicine.

Preview Only — Become a member for full access
SSRP Institute Oct 29, 2026
Dr. Seeds and Medivive Announce the Redox Smart Pen: A Novel Technology for Precise Peptide Administration
BREAKING NEWS WILLOUGHBY, Ohio [October 29, 2026] — Dr. Seeds and Medivive announce the launch of the Redox Smart Pen, an innovative pre-filled autoinjector peptide delivery system designed to improve precision and consistency in physician-directed peptide protocols. Importantly, the Redox Smart Pen was developed through a proprietary methodology focused on uniform potency, accuracy of administration, […]
READ NEWS
VIDEO
Cellular Medicine Mondays
Oct 26, 2026
Ep. 111 - Can BPC-157 & HBOT Prevent Amputation?
Preview only
Dissecting Protocols – Episode 111

Can BPC-157 & HBOT Prevent Amputation?

Dr. Seeds explores the potential and limitations of these investigational approaches, emphasizing the importance of blood flow, patient phenotyping, and cellular function in limb salvage. (Question Link)

Preview Only — Become a member for full access
PharmaNutra Oct 22, 2026
SSRP Institute Welcomes PharmaNutra as New Trusted Partner
PARTNER ANNOUNCEMENT WILLOUGHBY, Ohio, [October 22, 2026] — The SSRP Institute announces that PharmaNutra has joined its Trusted Partner Network following nomination and completion of the SSRP’s internal review process. Founded in Italy in 2003, PharmaNutra is a pharmaceutical and nutraceutical company focused on the research, development, and production of nutritional supplements and medical devices. […]
READ NEWS
VIDEO
Cellular Medicine Mondays
Oct 19, 2026
Ep. 110 - Phenotyping is Essential to Cellular Medicine
Preview only
Rabbit Holes – Episode 110

The Macrophage Mystery: Decoding Aging

In Part 3 of our Anti-Aging Mini Mastermind, Dr. Seeds explores how aging alters PGE2/EP2 signaling, influencing macrophage metabolism, immune function, and inflammation, and examines potential therapeutic implications.
Articles referenced: (2026 Article) (2021 Article)

Preview Only — Become a member for full access
VIDEO
Cellular Medicine Mondays
Oct 12, 2026
Ep. 109 - Anti-Aging Mini Mastermind Part 2
Preview only
Journal Club – Episode 109

Anti-Aging Mini Mastermind Part 2

In Part 2 of our Anti-Aging Mini Mastermind series, Dr. Seeds explores how PGE2 signaling and cellular metabolism influence inflammation, cognitive function, and aging, connecting foundational research to emerging discoveries in immunometabolism.  (2026 Article) (2021 Article)

Preview Only — Become a member for full access
ARTICLE
William Seeds, MD
Oct 8, 2026
EP2, Tissue-Resident Macrophages, and a New Mechanism of Organ Aging
William Seeds, MD Oct 8, 2026
EP2, Tissue-Resident Macrophages, and a New Mechanism of Organ Aging
Revisiting a Journal Club Article, “Restored clearance of senescent neutrophils by tissue-resident macrophages limits organ aging.” Science. 2026  Why This Paper Matters Most of the senescence conversation over the past decade has centered on a familiar cast: senescent fibroblasts, endothelial cells, adipocytes, and the drugs designed to clear them. This paper, which I discuss in […]
READ ARTICLE
VIDEO
Cellular Medicine Mondays
Oct 5, 2026
Ep. 108 - Dr. Seeds’ Office Hours
Preview only
Dr. Seeds’ Office Hours – Episode 108

Dr. Seeds’ Office Hours – Episode 108

Questions Answered:
1. ARA-290 for Post Op 47yo Male [0:53]
2. Cold Therapy and the Wim Hof Method [17:06]

Preview Only — Become a member for full access
Healthgevity Oct 2, 2026
Healthgevity Introduces hydraCELL+™, Featuring Formulation IP Developed by the Seeds Foundation for Cellular Research
BREAKING NEWS INTERLAKEN, N.J., [October 2, 2026] — Healthgevity, a practitioner-focused precision longevity nutrition company, announced the launch of hydraCELL+™, a cellular hydration and muscle-support formula built on proprietary formulation IP developed through the Seeds Foundation for Cellular Research and licensed to Healthgevity. The formula reflects the cellular medicine approach advanced by William Seeds, MD, and […]
READ NEWS
VIDEO
Cellular Medicine Mondays
Sep 28, 2026
Ep. 107 - Anti-Ageing Mini Mastermind Part 1
Preview only
Journal Club – Episode 107

Mini Anti-Aging Mastermind Part 1: Restored clearance of senescent neutrophils by tissue-resident macrophages limits organ aging

Part 1 of a special Mini Anti-Aging Mastermind inspired by the recent Science article exploring how impaired clearance of senescent neutrophils may contribute to age-related organ decline. Dr. Seeds begins breaking down the cellular mechanisms behind the research and what they reveal about the biology of aging. (Article Link)

Preview Only — Become a member for full access

Subscribe to the SSRP Community Digest

Get the latest research and developments in the field of Cellular Medicine straight to your inbox every month.

This field is for validation purposes and should be left unchanged.